http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005118576-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-025 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate | 2001-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_102fe6bd1eee818dc2f36c560ef0cb0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e926259f093a17f310dedf165ebf6b49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b2b4e8e3a9f0b77fc7ecb591e65dba |
| publicationDate | 2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005118576-A1 |
| titleOfInvention | Novel method and assays for yeast-based drug screening |
| abstract | The present invention provides a method wherein yeast mutants deficient in the expression of the yeast homolog of frataxin are applied for the identification and/or evaluation of pharmaceutically active compounds. n The invention concerns especially a method wherein the yeast strain W303-1B/Δydl120w::Kan R is applied for the identification and/or evaluation of chemical and biochemical compounds that protect W303-1B/Δydl120w::Kan R yeast from chemical stress. Furthermore, the invention concerns the application of said method in new cell-based assays to be used for drug screening. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006160063-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010083327-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010083327-A2 |
| priorityDate | 2000-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 212.